These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 30823868)

  • 1. Letter to the editor regarding European Headache Federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention.
    Nichols R; Skljarevski V; Dell'Agnello G; Hundemer HP; Aurora SK
    J Headache Pain; 2019 Mar; 20(1):22. PubMed ID: 30823868
    [No Abstract]   [Full Text] [Related]  

  • 2. European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention.
    Sacco S; Bendtsen L; Ashina M; Reuter U; Terwindt G; Mitsikostas DD; Martelletti P
    J Headache Pain; 2019 Jan; 20(1):6. PubMed ID: 30651064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Calcitonin Gene-Related Peptide (CGRP) Therapies: Update on a Previous Review After the American Headache Society 60th Scientific Meeting, San Francisco, June 2018.
    Tepper SJ
    Headache; 2018 Nov; 58 Suppl 3():276-290. PubMed ID: 30403405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recommendations on the Use of Anti-CGRP Monoclonal Antibodies in Children and Adolescents.
    Szperka CL; VanderPluym J; Orr SL; Oakley CB; Qubty W; Patniyot I; Lagman-Bartolome AM; Morris C; Gautreaux J; Victorio MC; Hagler S; Narula S; Candee MS; Cleves-Bayon C; Rao R; Fryer RH; Bicknese AR; Yonker M; Hershey AD; Powers SW; Goadsby PJ; Gelfand AA
    Headache; 2018 Nov; 58(10):1658-1669. PubMed ID: 30324723
    [No Abstract]   [Full Text] [Related]  

  • 5. History and Review of anti-Calcitonin Gene-Related Peptide (CGRP) Therapies: From Translational Research to Treatment.
    Tepper SJ
    Headache; 2018 Nov; 58 Suppl 3():238-275. PubMed ID: 30242830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcitonin gene-related peptide - beyond migraine prophylaxis.
    Olesen J; Ashina M
    Nat Rev Neurol; 2019 Oct; 15(10):562-564. PubMed ID: 31488896
    [No Abstract]   [Full Text] [Related]  

  • 7. Calcitonin Gene-Related Protein (CGRP)-Targeted Treatments for Migraine Prevention.
    Tepper DE
    Headache; 2019 Mar; 59(3):477-480. PubMed ID: 30825209
    [No Abstract]   [Full Text] [Related]  

  • 8. [Novel migraine treatment with CGRP-related monoclonal antibodies].
    Shibata M
    Rinsho Shinkeigaku; 2020 Oct; 60(10):668-676. PubMed ID: 32893246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CGRP Pathway in Migraine as a Viable Target for Therapies.
    Edvinsson L
    Headache; 2018 May; 58 Suppl 1():33-47. PubMed ID: 29697153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CGRP and Migraine: The Role of Blocking Calcitonin Gene-Related Peptide Ligand and Receptor in the Management of Migraine.
    Maasumi K; Michael RL; Rapoport AM
    Drugs; 2018 Jun; 78(9):913-928. PubMed ID: 29869205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How to integrate monoclonal antibodies targeting the calcitonin gene-related peptide or its receptor in daily clinical practice.
    Tiseo C; Ornello R; Pistoia F; Sacco S
    J Headache Pain; 2019 May; 20(1):49. PubMed ID: 31060490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Letter to the editor: European headache federation guidelines on the use of monoclonal antibodies acting on the calcitonin gene-related peptide or its receptor for migraine prevention.
    Mikol DD; Snellman J
    J Headache Pain; 2019 Jun; 20(1):67. PubMed ID: 31164079
    [No Abstract]   [Full Text] [Related]  

  • 13. CGRP, a target for preventive therapy in migraine and cluster headache: Systematic review of clinical data.
    Khan S; Olesen A; Ashina M
    Cephalalgia; 2019 Mar; 39(3):374-389. PubMed ID: 29110503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CGRP ligand and receptor monoclonal antibodies for migraine prevention: Evidence review and clinical implications.
    Dodick DW
    Cephalalgia; 2019 Mar; 39(3):445-458. PubMed ID: 30661365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Review of Monoclonal Antibody Therapies and Other Preventative Treatments in Migraine.
    Reuter U
    Headache; 2018 May; 58 Suppl 1():48-59. PubMed ID: 29697156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcitonin Gene-Related Peptide Monoclonal Antibody Use for the Preventive Treatment of Refractory Headache Disorders in Adolescents.
    Greene KA; Gentile CP; Szperka CL; Yonker M; Gelfand AA; Grimes B; Irwin SL
    Pediatr Neurol; 2021 Jan; 114():62-67. PubMed ID: 33232919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Modern migraine therapy-interdisciplinary long-term care].
    Göbel H; Heinze A; Heinze-Kuhn K; Göbel CHH
    Internist (Berl); 2020 Mar; 61(3):326-332. PubMed ID: 32072189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Proposal for Acronyms for Anti-Calcitonin Gene-Related Peptide Antibodies.
    Evans RW; Loftus BD
    Headache; 2018 Apr; 58(4):596. PubMed ID: 29611192
    [No Abstract]   [Full Text] [Related]  

  • 19. European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention - 2022 update.
    Sacco S; Amin FM; Ashina M; Bendtsen L; Deligianni CI; Gil-Gouveia R; Katsarava Z; MaassenVanDenBrink A; Martelletti P; Mitsikostas DD; Ornello R; Reuter U; Sanchez-Del-Rio M; Sinclair AJ; Terwindt G; Uluduz D; Versijpt J; Lampl C
    J Headache Pain; 2022 Jun; 23(1):67. PubMed ID: 35690723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CGRP inhibitors for migraine prophylaxis: a safety review.
    Rivera-Mancilla E; Villalón CM; MaassenVanDenBrink A
    Expert Opin Drug Saf; 2020 Oct; 19(10):1237-1250. PubMed ID: 32811190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.